GB2472790A - Dermatological preparations comprising microbes. - Google Patents
Dermatological preparations comprising microbes. Download PDFInfo
- Publication number
- GB2472790A GB2472790A GB0914364A GB0914364A GB2472790A GB 2472790 A GB2472790 A GB 2472790A GB 0914364 A GB0914364 A GB 0914364A GB 0914364 A GB0914364 A GB 0914364A GB 2472790 A GB2472790 A GB 2472790A
- Authority
- GB
- United Kingdom
- Prior art keywords
- skin
- microorganisms
- lactobacillus
- products described
- aspergillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title 1
- 244000005700 microbiome Species 0.000 claims abstract description 31
- 230000036541 health Effects 0.000 claims abstract description 9
- 230000035807 sensation Effects 0.000 claims abstract description 8
- 235000019615 sensations Nutrition 0.000 claims abstract description 8
- 210000003491 skin Anatomy 0.000 claims description 27
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 210000004927 skin cell Anatomy 0.000 claims description 5
- 230000006378 damage Effects 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims 3
- 241000186361 Actinobacteria <class> Species 0.000 claims 2
- 240000006439 Aspergillus oryzae Species 0.000 claims 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims 2
- 241000233866 Fungi Species 0.000 claims 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims 2
- 241000192001 Pediococcus Species 0.000 claims 2
- 241000190932 Rhodopseudomonas Species 0.000 claims 2
- 241000235070 Saccharomyces Species 0.000 claims 2
- 241000187747 Streptomyces Species 0.000 claims 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims 2
- 241000228212 Aspergillus Species 0.000 claims 1
- 241000892910 Aspergillus foetidus Species 0.000 claims 1
- 241001480052 Aspergillus japonicus Species 0.000 claims 1
- 241000228245 Aspergillus niger Species 0.000 claims 1
- 241000131386 Aspergillus sojae Species 0.000 claims 1
- 241000134719 Aspergillus tamarii Species 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 241000191366 Chlorobium Species 0.000 claims 1
- 241000191363 Chlorobium limicola Species 0.000 claims 1
- 241000190831 Chromatium Species 0.000 claims 1
- 241000235646 Cyberlindnera jadinii Species 0.000 claims 1
- 102000053602 DNA Human genes 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 240000001046 Lactobacillus acidophilus Species 0.000 claims 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims 1
- 244000199866 Lactobacillus casei Species 0.000 claims 1
- 235000013958 Lactobacillus casei Nutrition 0.000 claims 1
- 241001468157 Lactobacillus johnsonii Species 0.000 claims 1
- 241000186605 Lactobacillus paracasei Species 0.000 claims 1
- 240000006024 Lactobacillus plantarum Species 0.000 claims 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims 1
- 241000186604 Lactobacillus reuteri Species 0.000 claims 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims 1
- 241000187708 Micromonospora Species 0.000 claims 1
- 241000187724 Micromonospora chalcea Species 0.000 claims 1
- 241000235395 Mucor Species 0.000 claims 1
- 241000907556 Mucor hiemalis Species 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 241000187678 Nocardia asteroides Species 0.000 claims 1
- 241000186429 Propionibacterium Species 0.000 claims 1
- 241000186428 Propionibacterium freudenreichii Species 0.000 claims 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 claims 1
- 241000187693 Rhodococcus rhodochrous Species 0.000 claims 1
- 241000190967 Rhodospirillum Species 0.000 claims 1
- 241000190984 Rhodospirillum rubrum Species 0.000 claims 1
- 244000057717 Streptococcus lactis Species 0.000 claims 1
- 235000014897 Streptococcus lactis Nutrition 0.000 claims 1
- 241000194020 Streptococcus thermophilus Species 0.000 claims 1
- 241000187759 Streptomyces albus Species 0.000 claims 1
- 241000933216 Streptomyces roseoverticillatus Species 0.000 claims 1
- 230000008901 benefit Effects 0.000 claims 1
- 230000008859 change Effects 0.000 claims 1
- 229940023064 escherichia coli Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims 1
- 229940017800 lactobacillus casei Drugs 0.000 claims 1
- 229940072205 lactobacillus plantarum Drugs 0.000 claims 1
- 229940001882 lactobacillus reuteri Drugs 0.000 claims 1
- 241000512250 phototrophic bacterium Species 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 229920002477 rna polymer Polymers 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000007246 mechanism Effects 0.000 description 4
- 230000004075 alteration Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to products applied to the skin, containing living microorganisms which improve the appearance, health, taste, odour or sensation of the skin.
Description
Background
The ingestion of probiotics is now commonplace in many countries across the world.
Probiotics consist of live microorganisms which when ingested in adequate amounts confer a health benefit on the host.
Studies have shown that human skin is the habitat for a large number of species, genera and phyla of microorganisms.
Skinbiota refers to a range of live microorganisms which when administered to the skin improve the health, appearance, odor, sensation, or taste of the skin.
Description of the Invention:
An object of the present invention is to confer an improvement in the health, appearance, odor, sensation, or taste of the skin through the application of products containing living microorganisms.
The inventor of the present invention has made extensive studies to achieve the above-mentioned objects. As a result, the inventors have discovered that a number of species, and combinations of species, have the ability to improve the health, appearance, odor, sensation, or taste of the skin (or a combination thereof) through a variety of mechanisms.
One example mechanism is the increase in colonization of the skin by a variety of microorganisms which produce anti-oxidant compounds and vitamins. Another example mechanism is the increase in colonization of the skin by microorganisms which produce an odor more pleasant than average body odor. Another example mechanism is the increase in the colonization of the skin by microorganisms which beneficially alter the deoxyrihnucleic acid (dna) and/or rihonucleic acid (ma) of skin cells or reduce the number of microorganisms which have the potential to damage the dna and/or ma of skin cells.
The microorganisms were identified and applied to the skin through a variety of methods including for example in the form of a skin moisturizing cream, a bath additive and a skin wash.
An example product took the form of a liquid containing living microorganisms which when applied as a foot soak resulted in the improvement of foot odor due to an alteration in the population of microorganisms living on the skin of the foot and an alteration in the ph level of the foot skin.
A further example product took the form of a moisturizing cream which contained living microorganisms. The cream was applied to the face and resulted in an alteration in the makeup of microorganisms population of the skin. The living microorganisms included in the cream were selected partly because they were known to produce antioxidant compounds as a result of their metabolic processes.
Antioxidant compounds are known to limit the oxidative damage resulting from Reactive Oxygen Species. Reactive oxygen species damage proteins, nucleic acids, lipids, and other components (biomolecules) in living cells and may contribute to aging. The application of antioxidants to the skin has been demonstrated to improve the appearance of skin and reduce the effects of aging in some instances.
A further example product took the form of a skin cream containing living microorganisms which improved the health of skin suffering from eczema.
A further example product took the form of a liquid gel containing living microorganisms which improved the health of and sensation felt by skin suffering from psoriasis.
A further example product took the form of a bath additive containing living microorganisms which produce a mild lactic acid. The product when applied over time lowered the ph of the skin and improved its appearance.
Claims (12)
- Claims 1. Products which contain living microorganisms which are applied to skin and result in the improvement of the health, appearance, odor, taste or sensation of skin.
- 2. Products which contain living microorganisms which are applied to the skin and result in a change in the population of the microorganisms living on the skin conferring a benefit to the health, appearance, odor, taste or sensation of skin.
- 3. Products described in any of claims 1 to 2 which take the form selected form one of the following: cream, liquid, spray, gel, powder, wash, bath additive, shampoo, or soap.
- 4. Products described in any of the claims 1 to 3 which increase the numbers of microorganisms on the skin which beneficially alter the deoxyribonucleic acid (dna) and/or ribonucleic acid (ma) contained within skin cells or reduce the number of microorganisms which have the potential to damage the dna and/or ma of skin cells
- 5. Products described in any of claims 1 to 4 above which result in the reduction of skin-inhabiting microorganisms harmful or potentially harmful to the appearance, health, odor, taste or sensation of the skin.
- 6. Products described in any of claims 1 to 5 above which contain microorganisms which produce anti-oxidant compounds as a result of their metabolic processes.
- 7. Products described in any of claims 1 to 6 above which contain living microorganisms selected from the groups actinomycetes, phototropic bacteria, lactic acid bacteria, yeast and mould fungi wherein: said actinomycetes belong to genus Streptomyces, Streptoverticillium, Nocardia, Micromonospora, or Rhodococcus said phototrophic bacteria belong to genus Rhodopseudomonas, Rhodospirillum, Chromatium or Chlorobium said lactic acid bacteria belong to genus Lactobacillus, Propionibacterium, or Pediococcus; said yeast belong to genus Saccharomyces or Candida; and said mou'd fungi heong to genus Aspergillus or Mucor.
- 8. Products described in any of claims 1 to 7 above which contain living microorganisms selected from Streptomyces albus, Streptoverticillium baldaccii, Nocardia asteroides, Micromonospora chalcea or Rhodococcus rhodochrous, Rhodopseudomonas spheroids, Rhodospirillum rubrum, Chlorobium limicola, Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus johnsonii, Lactobacillus paracasei Escherichia coli, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosus, Saccharomyces cerevisiae Bifidobacterium species, Streptococcus thermophilus, Propionibacterium freudenreichii, Pediococcus halophilous, Streptococcus lactis, Streptococcus faecalis, Aspergillus japonicus, Aspergillus oryzae, Aspergillus sojae, Aspergillus tamarii, Aspergillus foetidus, Aspergillus niger, Aspergillus oryzae, Mucor hiemalis, Saccharomyces cerevisiae, Saccharomyces lactis and Candida utilis.
- 9. Products described in any of claims 1 to 8 above which contain living microorganisms selected because of their ability to produce anti-oxidant compounds or vitamins.
- 10. Products described in any of claims 1 to 9 above which contain living microorganisms selected because of their ability to produce anti-oxidant compounds which reduce damage to skin cells caused by Reactive Oxygen Species.
- 11. Products described in any of claims 1 to 10 above which contain living microorganisms selected because of their ability to produce either acid or alkaline compounds and therefore alter the ph level of the skin.
- 12. Products described in any of claims 1 to 11 above which contain living microorganisms which have been genetically modified.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0914364A GB2472790A (en) | 2009-08-18 | 2009-08-18 | Dermatological preparations comprising microbes. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0914364A GB2472790A (en) | 2009-08-18 | 2009-08-18 | Dermatological preparations comprising microbes. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB0914364D0 GB0914364D0 (en) | 2009-09-30 |
| GB2472790A true GB2472790A (en) | 2011-02-23 |
Family
ID=41171507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0914364A Withdrawn GB2472790A (en) | 2009-08-18 | 2009-08-18 | Dermatological preparations comprising microbes. |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2472790A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107412027A (en) * | 2017-08-02 | 2017-12-01 | 上海交通大学 | One primary yeast living cells facial mask and preparation method thereof and application method |
| CN108486005A (en) * | 2018-03-20 | 2018-09-04 | 商丘职业技术学院 | The preparation method and application of antioxidant of microbial food |
| US10806769B2 (en) | 2016-03-31 | 2020-10-20 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| US10874700B2 (en) | 2016-03-31 | 2020-12-29 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| US11564879B2 (en) | 2016-11-23 | 2023-01-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003022255A2 (en) * | 2001-09-05 | 2003-03-20 | Vsl Pharmaceuticals, Inc. | Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy |
| WO2003057380A2 (en) * | 2002-01-11 | 2003-07-17 | Whitlock David R | Compositions including ammonia oxidizing bacteria and methods of using same |
| US20040234455A1 (en) * | 2001-07-31 | 2004-11-25 | Szalay Aladar A. | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| WO2005030230A1 (en) * | 2003-09-30 | 2005-04-07 | Probiomics Limited | Compositions and methods for treatment or prevention of psoriasis and related disorders |
| US20060002910A1 (en) * | 1999-12-22 | 2006-01-05 | Markus Baur | Agent for the anti-adhesion of skin pathogenic flora |
| WO2009000875A2 (en) * | 2007-06-27 | 2008-12-31 | Chr. Hansen A/S | Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis |
| US20090123429A1 (en) * | 2004-11-03 | 2009-05-14 | Biovite Australia Pty Ltd | Arthrospira-based compositions and uses thereof |
| US20090130073A1 (en) * | 2005-09-19 | 2009-05-21 | Basf Se | Microorganisms Inhibiting the Formation of Foot Malodor |
-
2009
- 2009-08-18 GB GB0914364A patent/GB2472790A/en not_active Withdrawn
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060002910A1 (en) * | 1999-12-22 | 2006-01-05 | Markus Baur | Agent for the anti-adhesion of skin pathogenic flora |
| US20040234455A1 (en) * | 2001-07-31 | 2004-11-25 | Szalay Aladar A. | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| WO2003022255A2 (en) * | 2001-09-05 | 2003-03-20 | Vsl Pharmaceuticals, Inc. | Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy |
| WO2003057380A2 (en) * | 2002-01-11 | 2003-07-17 | Whitlock David R | Compositions including ammonia oxidizing bacteria and methods of using same |
| WO2005030230A1 (en) * | 2003-09-30 | 2005-04-07 | Probiomics Limited | Compositions and methods for treatment or prevention of psoriasis and related disorders |
| US20090123429A1 (en) * | 2004-11-03 | 2009-05-14 | Biovite Australia Pty Ltd | Arthrospira-based compositions and uses thereof |
| US20090130073A1 (en) * | 2005-09-19 | 2009-05-21 | Basf Se | Microorganisms Inhibiting the Formation of Foot Malodor |
| WO2009000875A2 (en) * | 2007-06-27 | 2008-12-31 | Chr. Hansen A/S | Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10806769B2 (en) | 2016-03-31 | 2020-10-20 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| US10874700B2 (en) | 2016-03-31 | 2020-12-29 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| US11633451B2 (en) | 2016-03-31 | 2023-04-25 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| US11998575B2 (en) | 2016-03-31 | 2024-06-04 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| US11564879B2 (en) | 2016-11-23 | 2023-01-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| CN107412027A (en) * | 2017-08-02 | 2017-12-01 | 上海交通大学 | One primary yeast living cells facial mask and preparation method thereof and application method |
| CN108486005A (en) * | 2018-03-20 | 2018-09-04 | 商丘职业技术学院 | The preparation method and application of antioxidant of microbial food |
Also Published As
| Publication number | Publication date |
|---|---|
| GB0914364D0 (en) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| de Souza et al. | Protective, technological, and functional properties of select autochthonous lactic acid bacteria from goat dairy products | |
| Shen et al. | In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians | |
| US20190298781A1 (en) | Method of Reducing the Likelihood of Skin Cancer in an Individual Human Being | |
| AU2003212265A1 (en) | Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations | |
| US20100291049A1 (en) | Anti-wrinkle agent | |
| Chung et al. | Synthesis of conjugated linoleic acid by human-derived Bifidobacterium breve LMC 017: utilization as a functional starter culture for milk fermentation | |
| GB2472790A (en) | Dermatological preparations comprising microbes. | |
| FR2914189A1 (en) | USE OF A LIPOPOLYSACCHARIDE FRACTION OF VITREOSCILLA FILIFORMIS AS AGENT STIMULATING THE SYNTHESIS OF ANTIMICROBIAL PEPTIDES OF THE SKIN. | |
| AU2007313580B2 (en) | Animal feed additive and animal feed | |
| KR101425716B1 (en) | Novel Strain of Lactobacillus fermentum spp., Cosmetic Composition Using the same and Preparation Method thereof | |
| Hayes et al. | Bioactive compounds from fermented food products | |
| CN111465386B (en) | Cosmetic composition for improving skin wrinkles comprising lactobacillus plantarum culture | |
| KR102133689B1 (en) | Manufacturing method of conjugate between lava seawater-originated minerals and dermabiotics-derived nucleotide, and functional dermabiotics cosmetic composition using the mineral-nucleotide | |
| Gueniche et al. | A combination of Vitreoscilla filiformis extract and Vichy volcanic mineralizing water strengthens the skin defenses and skin barrier | |
| JP2015096476A (en) | Composition for collagen production promotion, composition for collagen absorption promotion, and composition for anti-obesity | |
| Xu et al. | Probiotic activity of ropy Lactiplantibacillus plantarum NA isolated from Chinese northeast sauerkraut and comparative evaluation of its live and heat-killed cells on antioxidant activity and RAW 264.7 macrophage stimulation | |
| Arora et al. | Evolving advances in the cosmetic use of probiotics and postbiotics: health, regulatory and marketing aspects | |
| CN111991280A (en) | Anti-allergy bean fermentation extract, product and preparation method thereof | |
| US11998574B2 (en) | Method and system for modulating an individual's skin microbiome | |
| US20210268035A1 (en) | Composition containing a vital probiotic culture for human or veterinary use as a deodorant | |
| Kimoto-Nira et al. | Different growth media alter the induction of interleukin 12 by a Lactococcus lactis strain | |
| KR101773369B1 (en) | Sparassis crispa fermentation product having antioxidative and immunological activity, and preparing method thereof | |
| US12128074B2 (en) | External agent for hair growth or hair loss prevention | |
| Sharma et al. | Mechanistic role of probiotics in improving skin health | |
| Polyanskaya et al. | Bio-elements in functional foods. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |